Joint Stakeholder Meeting October 15, 2021 PDMP

September 29, 2021

The State Board of Pharmacy, State Board of Nursing, Colorado Medical Board, Colorado Dental Board, Colorado Podiatry Board, State Board of Veterinary Medicine, and State Board of Optometry will hold a Joint Stakeholder Meeting to gather feedback to identify and create a list of prescription drugs and substances (using evidence-based practices), in addition to controlled substances, that have a substantial potential for abuse and must require pharmacists and prescription drug outlets to report those prescription drugs and substances to the Prescription Drug Monitoring Program (PDMP) when dispensed to a patient. The Board is considering the development of new rules to track and monitor additional prescription drugs/substances, as allowed per section 12-280-404(2)(b)(I), C.R.S., of Colorado Senate Bill 21-098.

Meeting Information

  • Friday, October 15, 2021, at 11:30 A.M. (MDT)

New Legislation

Ways to Participate

  • Webinar Registration 
  • Submit Written Comments: Oral comments will be taken from participants who are present via webinar. If you cannot attend the meeting virtually or wish to make written comments rather than speaking, you may email your written comments to: [email protected]. Please submit your comments by Wednesday, October 13, 2021.  

Meeting Format

The State Board of Pharmacy (Board) encourages stakeholders to provide comments on the new legislation, and help identify a list of non-controlled prescription drugs/substances that should be tracked and monitored by the PDMP.  All written and oral comments will be provided to the Board before any permanent rule revisions are considered. If you have any questions or concerns about stakeholder input or the rulemaking process, please send them to [email protected].